Explaining the escalation of drug use in substance dependence:: Models and appropriate animal laboratory tests

被引:99
|
作者
Zernig, Gerald
Ahmed, Serge H.
Cardinal, Rudolf N.
Morgan, Drake
Acquas, Elio
Foltin, Richard W.
Vezina, Paul
Negus, S. Stevens
Crespo, Jose A.
Stoeckl, Petra
Grubinger, Petra
Madlung, Ekkehard
Haring, Christian
Kurz, Martin
Saria, Alois
机构
[1] Med Univ Innsbruck, Dept Psychiat, Expt Psychiat Unit, A-6020 Innsbruck, Austria
[2] Med Univ Innsbruck, Substance Abuse Treatment Ctr, A-6020 Innsbruck, Austria
[3] Psychiat Hosp Tirol, Primariat B, Tyrol, Austria
[4] Univ Bordeaux 2, CNRS, UMR 5227, F-33076 Bordeaux, France
[5] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 1TN, England
[6] Univ Florida, Coll Med, Dept Psychiat, Div Addict Med, Gainesville, FL 32611 USA
[7] Columbia Univ, New York State Psychiat Inst, Dept Psychiat, New York, NY 10027 USA
[8] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA
[9] Harvard Univ, McLean Hosp, Alcohol & Drug Abuse Res Ctr, Belmont, MA 02178 USA
[10] Univ Cagliari, Dept Toxicol, I-09124 Cagliari, Italy
[11] Univ Cagliari, Ctr Excellence Neurobiol Addict, I-09124 Cagliari, Italy
关键词
alcohol; amphetamine; baboon; clinical trial; cocaine; cognitive behavioral therapy; conditioned stimulus strength; drug abuse; drug dependence; habit formation; hedonic value; heroin; human; incentive salience; incentive value; methylenedioxymethamphetamine; morphine; nicotine; opioids; psychoanalysis; psychostimulants; psychotherapy; rat; rhesus monkey; remifentanil; review; reward allostasis; self-administration; sensitization; squirrel monkey; subjective effect; tolerance;
D O I
10.1159/000103923
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Escalation of drug use, a hallmark of drug dependence, has traditionally been interpreted as reflecting the development of tolerance to the drug's effects. However, on the basis of animal behavioral data, several groups have recently proposed alternative explanations, i.e. that such an escalation of drug use might not be based on ( 1) tolerance, but rather be indicative of (2) sensitization to the drug's reinforcing effect, 3) reward allostasis, ( 4) an increase in the incentive salience of drug-associated stimuli, ( 5) an increase in the reinforcing strength of the drug reinforcer relative to alternative reinforcers, or ( 6) habit formation. From the pharmacological perspective, models 1-3 allow predictions about the change in the shape of drug dose-effect curves that are based on mathematically defined models governing receptor-ligand interaction and signal transduction. These predictions are tested in the present review, which also describes the other currently championed models for drug use escalation and other components of apparent 'reinforcement' (in its original meaning, like 'tolerance' or 'sensitization', a purely descriptive term). It evaluates the animal experimental approaches employed to support or prove the existence of each of the models and reinforcement components, and recapitulates the clinical evidence, which strongly suggests that escalation of drug use is predominantly based on an increase in the frequency of intoxication events rather than an increase in the dose taken at each intoxication event. Two apparent discrepancies in animal experiments are that ( a) sensitization to overall reinforcement has been found more often for psychostimulants than for opioids, and that (b) tolerance to the reinforcing and other effects has been observed more often for opioids than for cocaine. These discrepancies are resolved by the finding that cocaine levels seem to be more tightly regulated at submaximum reinforcing levels than opioid levels are. Consequently, animals self-administering opioids are more likely to expose themselves to higher above-threshold doses than animals self-administering psychostimulants, rendering the development of tolerance to opioids more likely than tolerance to psychostimulants. The review concludes by making suggestions on how to improve the current behavioral experimental approaches. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:65 / 119
页数:55
相关论文
共 50 条
  • [41] SINGLE SCREENING QUESTIONS FOR UNHEALTHY ALCOHOL AND OTHER DRUG USE TO IDENTIFY SUBSTANCE DEPENDENCE
    Saitz, R.
    Cheng, D. M.
    Allensworth-Davies, D.
    Winter, M.
    Smith, P. C.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 115A - 115A
  • [42] Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors
    Butelman, Eduardo R.
    Chen, Carina Y.
    Brown, Kate G.
    Kreek, Mary Jeanne
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2019, 205
  • [43] Refining animal models in fracture research:: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use
    Auer, Jorg A.
    Goodship, Allen
    Arnoczky, Steven
    Pearce, Simon
    Price, Jill
    Claes, Lutz
    Von Rechenberg, Brigitte
    Hofmann-Amtenbrinck, Margarethe
    Schneider, Erich
    Mueller-Terpitz, R.
    Thiele, F.
    Rippe, Klaus-Peter
    Grainger, David W.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2007, 8 (1)
  • [44] Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use
    Jorg A Auer
    Allen Goodship
    Steven Arnoczky
    Simon Pearce
    Jill Price
    Lutz Claes
    Brigitte von Rechenberg
    Margarethe Hofmann-Amtenbrinck
    Erich Schneider
    R Müller-Terpitz
    F Thiele
    Klaus-Peter Rippe
    David W Grainger
    [J]. BMC Musculoskeletal Disorders, 8
  • [45] USE OF LABORATORY-ANIMAL MODELS IN INVESTIGATING EMPHYSEMA AND CIGARETTE-SMOKING IN HUMANS
    THOMAS, RD
    VIGERSTAD, TJ
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1989, 10 (03) : 264 - 271
  • [46] Appropriate use of animal models in the assessment of risk during prenatal development: An illustration using inorganic arsenic
    Holson, JF
    Desesso, JM
    Jacobson, CF
    Farr, CH
    [J]. TERATOLOGY, 2000, 62 (01) : 51 - 71
  • [47] Introduction to Special Issue on Animal Models of Neuropsychiatric Disorders and Substance Use Disorders: Progress and Gaps
    Smith, Mark A.
    Evans, Suzette M.
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 25 (02) : 61 - 63
  • [48] The use of wild animal models to detect evidence of environmental contamination by asbestos-like substance
    Puleio, R.
    Schiavo, M. R.
    Macaluso, G.
    Manno, C.
    Loria, G. R.
    [J]. VETERINARY RECORD, 2013, 172 (15) : 398 - +
  • [49] Spontaneous and genetically engineered animal models: use in preclinical cancer drug development
    Hansen, K
    Khanna, C
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (06) : 858 - 880
  • [50] A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence
    King, Kevin M.
    Chassin, Laurie
    [J]. JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2007, 68 (02) : 256 - 265